• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DNGR-1 介导的死亡细胞相关抗原的交叉呈递。

DNGR-1-mediated cross-presentation of dead cell-associated antigens.

机构信息

Immunobiology Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.

Immunobiology Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.

出版信息

Semin Immunol. 2023 Mar;66:101726. doi: 10.1016/j.smim.2023.101726. Epub 2023 Feb 7.

DOI:10.1016/j.smim.2023.101726
PMID:36758378
Abstract

Conventional dendritic cells type 1 (cDC1) are critical for inducing protective CD8 T cell responses to tumour and viral antigens. In many instances, cDC1 access those antigens in the form of material internalised from dying tumour or virally-infected cells. How cDC1 extract dead cell-associated antigens and cross-present them in the form of peptides bound to MHC class I molecules to CD8 T cells remains unclear. Here we review the biology of dendritic cell natural killer group receptor-1 (DNGR-1; also known as CLEC9A), a C-type lectin receptor highly expressed on cDC1 that plays a key role in this process. We highlight recent advances that support a function for DNGR-1 signalling in promoting inducible rupture of phagocytic or endocytic compartments containing dead cell debris, thereby making dead cell-associated antigens accessible to the endogenous MHC class I processing and presentation machinery of cDC1. We further review how DNGR-1 detects dead cells, as well as the functions of the receptor in anti-viral and anti-tumour immunity. Finally, we highlight how the study of DNGR-1 has opened new perspectives into cross-presentation, some of which may have applications in immunotherapy of cancer and vaccination against viral diseases.

摘要

传统树突状细胞 1 型 (cDC1) 对于诱导针对肿瘤和病毒抗原的保护性 CD8 T 细胞反应至关重要。在许多情况下,cDC1 以从死亡的肿瘤或病毒感染的细胞内化的物质形式获取这些抗原。cDC1 如何提取与死亡细胞相关的抗原,并以与 MHC Ⅰ类分子结合的肽形式呈递这些抗原以激活 CD8 T 细胞仍不清楚。在这里,我们回顾树突状细胞自然杀伤组受体 1(DNGR-1;也称为 CLEC9A)的生物学特性,DNGR-1 是一种在 cDC1 上高度表达的 C 型凝集素受体,在这个过程中起着关键作用。我们强调了最近的进展,这些进展支持了 DNGR-1 信号在促进含有死亡细胞碎片的吞噬或内吞隔室的诱导性破裂中的作用,从而使与死亡细胞相关的抗原可被 cDC1 内源性 MHC Ⅰ类加工和呈递机制识别。我们进一步回顾了 DNGR-1 如何检测死亡细胞,以及该受体在抗病毒和抗肿瘤免疫中的功能。最后,我们强调了 DNGR-1 的研究如何为交叉呈递开辟了新的视角,其中一些可能在癌症的免疫治疗和抗病毒疫苗接种中有应用。

相似文献

1
DNGR-1-mediated cross-presentation of dead cell-associated antigens.DNGR-1 介导的死亡细胞相关抗原的交叉呈递。
Semin Immunol. 2023 Mar;66:101726. doi: 10.1016/j.smim.2023.101726. Epub 2023 Feb 7.
2
SYK ubiquitination by CBL E3 ligases restrains cross-presentation of dead cell-associated antigens by type 1 dendritic cells.CBL E3 连接酶对 SYK 的泛素化抑制了 1 型树突状细胞对死细胞相关抗原的交叉呈递。
Cell Rep. 2023 Dec 26;42(12):113506. doi: 10.1016/j.celrep.2023.113506. Epub 2023 Nov 28.
3
Cross-presentation of dead-cell-associated antigens by DNGR-1 dendritic cells contributes to chronic allograft rejection in mice.DNGR-1 树突状细胞递呈死亡细胞相关抗原导致小鼠慢性移植排斥反应。
Eur J Immunol. 2020 Dec;50(12):2041-2054. doi: 10.1002/eji.201948501. Epub 2020 Jul 26.
4
Secreted gelsolin inhibits DNGR-1-dependent cross-presentation and cancer immunity.分泌型凝胶蛋白抑制 DNGR-1 依赖性交叉呈递和癌症免疫。
Cell. 2021 Jul 22;184(15):4016-4031.e22. doi: 10.1016/j.cell.2021.05.021. Epub 2021 Jun 2.
5
The receptor DNGR-1 signals for phagosomal rupture to promote cross-presentation of dead-cell-associated antigens.DNGR-1 受体通过信号转导促进吞噬体破裂,从而促进死亡细胞相关抗原的交叉呈递。
Nat Immunol. 2021 Feb;22(2):140-153. doi: 10.1038/s41590-020-00824-x. Epub 2020 Dec 21.
6
The DC receptor DNGR-1 mediates cross-priming of CTLs during vaccinia virus infection in mice.树突状细胞受体 DNGR-1 在小鼠痘病毒感染期间介导 CTL 的交叉呈递。
J Clin Invest. 2012 May;122(5):1628-43. doi: 10.1172/JCI60660. Epub 2012 Apr 16.
7
DNGR-1 is dispensable for CD8+ T-cell priming during respiratory syncytial virus infection.在呼吸道合胞病毒感染期间,DNGR-1对于CD8 + T细胞的启动是可有可无的。
Eur J Immunol. 2014 Aug;44(8):2340-8. doi: 10.1002/eji.201444454. Epub 2014 May 30.
8
The dendritic cell receptor DNGR-1 controls endocytic handling of necrotic cell antigens to favor cross-priming of CTLs in virus-infected mice.树突状细胞受体 DNGR-1 控制坏死细胞抗原的内吞处理,有利于病毒感染小鼠中 CTL 的交叉呈递。
J Clin Invest. 2012 May;122(5):1615-27. doi: 10.1172/JCI60644. Epub 2012 Apr 16.
9
DNGR-1, a Dendritic Cell-Specific Sensor of Tissue Damage That Dually Modulates Immunity and Inflammation.DNGR-1,一种树突状细胞特异性的组织损伤传感器,双重调节免疫和炎症。
Front Immunol. 2020 Feb 7;10:3146. doi: 10.3389/fimmu.2019.03146. eCollection 2019.
10
Myosin II Synergizes with F-Actin to Promote DNGR-1-Dependent Cross-Presentation of Dead Cell-Associated Antigens.肌球蛋白 II 与 F-肌动蛋白协同作用促进死亡细胞相关抗原的 DNGR-1 依赖性交叉呈递。
Cell Rep. 2018 Jul 10;24(2):419-428. doi: 10.1016/j.celrep.2018.06.038.

引用本文的文献

1
Comparing DC subsets in solid tumors: what about DC3s?比较实体瘤中的树突状细胞亚群:DC3s 呢?
Immunother Adv. 2025 May 30;5(1):ltaf021. doi: 10.1093/immadv/ltaf021. eCollection 2025.
2
cDC1s Promote Atherosclerosis via Local Immunity and Are Targetable for Therapy.浆细胞样树突状细胞1通过局部免疫促进动脉粥样硬化,且是可靶向治疗的。
Circ Res. 2025 Jul 18;137(3):400-416. doi: 10.1161/CIRCRESAHA.124.325792. Epub 2025 May 30.
3
Exploring Clec9a in dendritic cell-based tumor immunotherapy for molecular insights and therapeutic potentials.
探索Clec9a在基于树突状细胞的肿瘤免疫治疗中的分子见解和治疗潜力。
NPJ Vaccines. 2025 Feb 7;10(1):27. doi: 10.1038/s41541-025-01084-2.
4
Cross-priming in cancer immunology and immunotherapy.癌症免疫学与免疫治疗中的交叉呈递
Nat Rev Cancer. 2025 Apr;25(4):249-273. doi: 10.1038/s41568-024-00785-5. Epub 2025 Jan 29.
5
MHC class I-dressing is mediated via phosphatidylserine recognition and is enhanced by polyI:C.MHC I类分子修饰通过磷脂酰丝氨酸识别介导,并被聚肌胞苷酸增强。
iScience. 2024 Apr 10;27(5):109704. doi: 10.1016/j.isci.2024.109704. eCollection 2024 May 17.
6
Vitamin D regulates microbiome-dependent cancer immunity.维生素D调节微生物群依赖的癌症免疫。
Science. 2024 Apr 26;384(6694):428-437. doi: 10.1126/science.adh7954. Epub 2024 Apr 25.
7
Control of adaptive immunity by pattern recognition receptors.模式识别受体对适应性免疫的控制。
Immunity. 2024 Apr 9;57(4):632-648. doi: 10.1016/j.immuni.2024.03.014.
8
Effects of Golimumab and Ustekinumab on Circulating Dendritic Cell Migratory Capacity in Inflammatory Bowel Disease.戈利木单抗和优特克单抗对炎症性肠病患者循环树突状细胞迁移能力的影响
Biomedicines. 2023 Oct 18;11(10):2831. doi: 10.3390/biomedicines11102831.